Cargando…

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease

OBJECTIVE: to estimate survival, mortality and cause of death among users or not of hydroxyurea with sickle cell disease. METHOD: cohort study with retrospective data collection, from 1980 to 2010 of patients receiving inpatient treatment in two Brazilian public hospitals. The survival probability w...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Araujo, Olinda Maria Rodrigues, Ivo, Maria Lúcia, Ferreira, Marcos Antonio, Pontes, Elenir Rose Jardim Cury, Bispo, Ieda Maria Gonçalves Pacce, de Oliveira, Eveny Cristine Luna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376033/ https://www.ncbi.nlm.nih.gov/pubmed/25806633 http://dx.doi.org/10.1590/0104-1169.3385.2526

Ejemplares similares

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Scope and efficiency of the newborn screening program in identifying hemoglobin S
por: Ivo, Maria Lúcia, et al.
Publicado: (2014)

Non-viral microbial keratitis in adults: clinical and laboratory aspects
por: Cury, Eunice Stella Jardim, et al.
Publicado: (2018)

The incorporation of activities to control dengue by community health agents
por: Cazola, Luiza Helena de Oliveira, et al.
Publicado: (2014)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

Evaluation of epidural blockade as therapy for patients with sciatica secondary to lumbar disc herniation()
por: Nunes, Rogerio Carlos Sanfelice, et al.
Publicado: (2016)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach
por: Alberts, Nicole M, et al.
Publicado: (2020)

Vulnerability to AIDS among the elderly in an urban center in central Brazil
por: Driemeier, Marta, et al.
Publicado: (2012)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Public health policies for children and youth with special health care needs in OECD member countries and Brazil: A scoping review protocol
por: Gimenes, Ângela Cristina Rocha, et al.
Publicado: (2023)

Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2011)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

P-048: INFLUENCE OF SEVEN GENETIC POLYMORPHISMS ON THE RESPONSE TO SICKLE CELL DISEASE THERAPY WITH HYDROXYUREA
por: O., FRANCO SANTOS, et al.
Publicado: (2022)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS
por: dos Santos Ferreira, Rosângela, et al.
Publicado: (2016)

Hematological and biochemical findings in patients with dengue fever: a current issue
por: da Cunha, Rivaldo Venâncio, et al.
Publicado: (2012)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Effects of oxidative stress on liver, brain and spinal cord of rats using L-NAME and treated with hydroxyurea. A model of sickle cell complication()
por: dos Santos, Abilio Torres, et al.
Publicado: (2020)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease
por: Moreira, J. A., et al.
Publicado: (2016)

Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros
por: Santos, Fernanda Kelle de Souza, et al.
Publicado: (2011)

Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia
por: Vinhaes, Caian L., et al.
Publicado: (2020)

Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
por: Ward, Joel, et al.
Publicado: (2018)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
por: Yadav, Dhiraj Kumar, et al.
Publicado: (2020)

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
por: Nazon, Charlotte, et al.
Publicado: (2019)

A systematic review on hydroxyurea therapy for sickle cell disease in India
por: Pandey, Apoorva, et al.
Publicado: (2022)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: dos Santos Neres, Joelma Santana, et al.
Publicado: (2023)

Effectiveness of a bioactive food compound in anthropometric measures of individuals with HIV/AIDS: A nonrandomized trial
por: Ferreira, Rosângela dos Santos, et al.
Publicado: (2018)

Sickness absence among employees of the State Court of Campo Grande, Mato Grosso do Sul, Brazil
por: França, Giannine Roberta Marcelino de Souza, et al.
Publicado: (2019)

Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program
por: Nottage, Kerri A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9q5plfu6p1keubvip3vicv9l2b